CRISPR-U™ Gene Knockout Cell Line Strategy

CRKL Gene Knockout Strategy

CRISPR-U™ technology (CRISPR based), developed by Ubigene, is more efficient than general CRISPR/Cas9 technology in double-strand breaking and homologous recombination. With CRISPR-U™, Ubigene has successfully edited over 3000 genes on more than 100 types of cell lines.
Objective
To create a Human CRKL Knockout model in cell line by CRISPR-U™-mediated genome engineering.
Target gene info
Official symbol CRKL
Gene id 1399
Organism Homo sapiens
Official full symbol CRK like proto-oncogene, adaptor protein
Gene type protein-coding
Summary This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.
Genomic regions Chromosome 22
Strategy Summary
This gene has 1 protein coding transcripts:
Name Transcript ID bp Protein Biotype CCDS UniProt Match RefSeq Match Flags
CRKL-201 ENST00000354336.8 5342 303aa Protein coding CCDS13785 P46109 NM_005207.4 TSL:1, GENCODE basic, APPRIS P1, MANE Select v0.92,
CRKL-202 ENST00000411769.1 2037 303aa Nonsense mediated decay CCDS13785 P46109 - TSL:1,
Ubigene Red Cotton Transcript
Strategy
Click to get
Red Cotton™ Assessment    
Project Difficulty Level unknown
Target Gene CRKL
This KO Strategy loading
Red Cotton™ Notes Gene CRKL had been KO in hela cell line.
Aforementioned information comes from Ubigene database. Different origin of cell lines may have different condition. Ubigene reserved all the right for final explanation.
Special deals for this gene:

$49

Single gRNA plasmid off-shelf

$599

Single gRNA lentivirus

Work flow
Ubigene Red Cotton Workflow

Please leave your suggestion ×

Comment: